Drs Mandrola and Gillinov discuss the ACC late-breaking clinical trial testing rate- vs rhythm control for the management of atrial fibrillation after cardiac surgery.

Patient's ICD knowledge, letting pharmacists help manage CV risk, mitral-valve repair with CABG, shared decisions in the ED, and new recommendations on ASA are discussed in this week's podcast.

From ACC: rate vs rhythm for postop AF, TAVR in intermediate-risk AS, PCSK9 inhibitors for statin intolerance, HOPE-3, and FIRE and ICE are discussed as well as the approval of a leadless pacemaker.

Dr John Mandrola reviews new ways to think about statin benefits, breast artery calcification, FDA drug surveillance, NOACs before AF ablation, wearable cardiac defibrillators, and ACC2016 in this week's podcast.

Broken-heart syndrome, anticoagulation underuse, polypharmacy in the elderly, hematoma after device implants and new findings in HDL biology are reviewed by Dr John Mandrola in this week's podcast.

Drs Sudhir Kushwaha and Rocky Daly share their considerations in reverse-order heart-liver transplant cases at Mayo's Heart Transplant Clinic.

Traumatic ICH in elderly on OAC, medical therapy pre-ICD, yoga and AF, e-consultations, bioresorbable stents, and 6 ways to prevent patient deaths are topics discussed by Dr John Mandrola in this week's podcast.

Dr Naveen L Pereira talks to Dr Joerg Herrmann about the importance of bringing cardiology and oncology together and his hopes for the future for the new cardio-oncology clinic.

Dr Barry Carter discusses a trial suggesting that pharmacists working in primary care offices can help with difficult hypertension cases, and the cost-effectiveness of bringing on a pharmacist.

The NBA heart study, MitraClip safety notice, CAC and dementia, RAS blockade in patients with diabetes and hypertension, and lead damage after device generator change are discussed this week.